Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

  1. U.S. Preventive Services Task Force*
  1. From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
    1. Figure 1.
      View larger version:
      Figure 1. Aspirin for the prevention of cardiovascular disease: clinical summary of a U.S. Preventive Services Task Force recommendation statement.

      CHD = coronary heart disease; CVD = cardiovascular disease; GI = gastrointestinal; HDL = high-density lipoprotein; MI = myocardial infarction; NSAID = nonsteroidal anti-inflammatory drug; USPSTF = U.S. Preventive Services Task Force.

    2. Figure 2.
      View larger version:
      Figure 2. Estimated MIs prevented and estimated harms of using aspirin for 10 years in a hypothetical cohort of 1000 men.

      Estimates are based on age and 10-year CHD risk. CHD = coronary heart disease; GI = gastrointestinal; MI = myocardial infarction.

    3. Figure 3.
      View larger version:
      Figure 3. 10-year CHD risk levels at which the number of cardiovascular disease events prevented is closely balanced to the number of serious bleeding events.

      CHD = coronary heart disease.

    4. Figure 4.
      View larger version:
      Figure 4. Estimated number of strokes prevented and estimated harms of using aspirin for 10 years in a hypothetical cohort of 1000 women on the basis of age and 10-year stroke risk.

      GI = gastrointestinal.

    Responses to this article

    Related Articles

    Summary for Patients

    « Previous | Next Article »Table of Contents